CB2 cannabinoid receptors: new vistas
Good news for CB1 receptors: endogenous agonists are in the right place
Cannabinoid receptors and the regulation of bone mass
CB2 receptors in reproduction
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists
CB2 receptors in the brain: role in central immune function
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
Cannabinoid CB2 receptors in human brain inflammation
CB2 receptors as new therapeutic targets for liver diseases
Cannabinoid receptors in acute and chronic complications of atherosclerosis
CB2 receptor-mediated migration of immune cells: it can go either way
The peripheral cannabinoid receptor knockout mice: an update
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
CB2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration
In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models